Literature DB >> 24370833

Cone dystrophy with "supernormal" rod ERG: psychophysical testing shows comparable rod and cone temporal sensitivity losses with no gain in rod function.

Andrew Stockman1, G Bruce Henning, Michel Michaelides, Anthony T Moore, Andrew R Webster, Jocelyn Cammack, Caterina Ripamonti.   

Abstract

PURPOSE: We report a psychophysical investigation of 5 observers with the retinal disorder "cone dystrophy with supernormal rod ERG," caused by mutations in the gene KCNV2 that encodes a voltage-gated potassium channel found in rod and cone photoreceptors. We compared losses for rod- and for cone-mediated vision to further investigate the disorder and to assess whether the supernormal ERG is associated with any visual benefit.
METHODS: L-cone, S-cone, and rod temporal acuity (critical flicker fusion frequency) were measured as a function of target irradiance; L-cone temporal contrast sensitivity was measured as a function of temporal frequency.
RESULTS: Temporal acuity measures revealed that losses for vision mediated by rods, S-cones, and L-cones are roughly equivalent. Further, the gain in rod function implied by the supernormal ERG provides no apparent benefit to near-threshold rod-mediated visual performance. The L-cone temporal contrast sensitivity function in affected observers was similar in shape to the mean normal function but only after the mean function was compressed by halving the logarithmic sensitivities.
CONCLUSIONS: The name of this disorder is potentially misleading because the comparable losses found across rod and cone vision suggest that the disorder is a generalized cone-rod dystrophy. Temporal acuity and temporal contrast sensitivity measures are broadly consistent with the defect in the voltage-gated potassium channel producing a nonlinear distortion of the photoreceptor response but after otherwise normal transduction processes.

Entities:  

Keywords:  KCNV2 gene; cone dystrophy; cone-rod dystrophies; critical flicker fusion; flicker sensitivity; supernormal rod ERG; temporal acuity; temporal processing

Mesh:

Substances:

Year:  2014        PMID: 24370833     DOI: 10.1167/iovs.13-12919

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Two-color pupillometry in KCNV2 retinopathy.

Authors:  Frederick T Collison; Jason C Park; Gerald A Fishman; Edwin M Stone; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2019-03-29       Impact factor: 2.379

2.  Differential impact of Kv8.2 loss on rod and cone signaling and degeneration.

Authors:  Shivangi M Inamdar; Colten K Lankford; Deepak Poria; Joseph G Laird; Eduardo Solessio; Vladimir J Kefalov; Sheila A Baker
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 5.121

3.  Heteromeric KV2/KV8.2 Channels Mediate Delayed Rectifier Potassium Currents in Primate Photoreceptors.

Authors:  Jacqueline Gayet-Primo; Daniel B Yaeger; Roupen A Khanjian; Teresa Puthussery
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

4.  KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1.

Authors:  Michalis Georgiou; Anthony G Robson; Kaoru Fujinami; Shaun M Leo; Ajoy Vincent; Fadi Nasser; Thales Antônio Cabral De Guimarães; Samer Khateb; Nikolas Pontikos; Yu Fujinami-Yokokawa; Xiao Liu; Kazushige Tsunoda; Takaaki Hayashi; Mauricio E Vargas; Alberta A H J Thiadens; Emanuel R de Carvalho; Xuan-Thanh-An Nguyen; Gavin Arno; Omar A Mahroo; Maria Inmaculada Martin-Merida; Belen Jimenez-Rolando; Gema Gordo; Ester Carreño; Ayuso Carmen; Dror Sharon; Susanne Kohl; Rachel M Huckfeldt; Bernd Wissinger; Camiel J F Boon; Eyal Banin; Mark E Pennesi; Arif O Khan; Andrew R Webster; Eberhart Zrenner; Elise Héon; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2020-12-11       Impact factor: 5.258

5.  Psychophysical measures of visual function and everyday perceptual experience in a case of congenital stationary night blindness.

Authors:  Jocelyn Cammack; John Whight; Vinette Cross; Andrew T Rider; Andrew R Webster; Andrew Stockman
Journal:  Clin Ophthalmol       Date:  2016-08-22

6.  The Pattern of Retinal Ganglion Cell Loss in OPA1-Related Autosomal Dominant Optic Atrophy Inferred From Temporal, Spatial, and Chromatic Sensitivity Losses.

Authors:  Anna Majander; Catarina João; Andrew T Rider; G Bruce Henning; Marcela Votruba; Anthony T Moore; Patrick Yu-Wai-Man; Andrew Stockman
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

Review 7.  KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy.

Authors:  Thales A C De Guimaraes; Michalis Georgiou; Anthony G Robson; Michel Michaelides
Journal:  Ophthalmic Genet       Date:  2020-05-22       Impact factor: 1.803

8.  The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy.

Authors:  A Majander; A G Robson; C João; G E Holder; P F Chinnery; A T Moore; M Votruba; A Stockman; P Yu-Wai-Man
Journal:  Mitochondrion       Date:  2017-07-18       Impact factor: 4.160

Review 9.  Noncanonical Ion Channel Behaviour in Pain.

Authors:  Cosmin I Ciotu; Christoforos Tsantoulas; Jannis Meents; Angelika Lampert; Stephen B McMahon; Andreas Ludwig; Michael J M Fischer
Journal:  Int J Mol Sci       Date:  2019-09-15       Impact factor: 5.923

10.  KCNV2-Associated Retinopathy: Detailed Retinal Phenotype and Structural Endpoints-KCNV2 Study Group Report 2.

Authors:  Michalis Georgiou; Kaoru Fujinami; Ajoy Vincent; Fadi Nasser; Samer Khateb; Mauricio E Vargas; Alberta A H J Thiadens; Emanuel R de Carvalho; Xuan-Thanh-An Nguyen; Thales Antônio Cabral De Guimarães; Anthony G Robson; Omar A Mahroo; Nikolas Pontikos; Gavin Arno; Yu Fujinami-Yokokawa; Shaun Michael Leo; Xiao Liu; Kazushige Tsunoda; Takaaki Hayashi; Belen Jimenez-Rolando; Maria Inmaculada Martin-Merida; Almudena Avila-Fernandez; Ester Carreño; Blanca Garcia-Sandoval; Carmen Ayuso; Dror Sharon; Susanne Kohl; Rachel M Huckfeldt; Camiel J F Boon; Eyal Banin; Mark E Pennesi; Bernd Wissinger; Andrew R Webster; Elise Héon; Arif O Khan; Eberhart Zrenner; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2021-03-15       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.